^
BIOMARKER:

Chr t(4;14)

Chr t(4;14)
Multiple Myeloma
DVD
Sensitive: B - Late Trials
Chr t(4;14)
Multiple Myeloma
daratumumab
Sensitive: B - Late Trials
Chr t(4;14)
Multiple Myeloma
Isa-KRd
Sensitive: C2 – Inclusion Criteria
Chr t(4;14)
Multiple Myeloma
lenalidomide + ixazomib
Sensitive: C3 – Early Trials
Chr t(4;14)
Multiple Myeloma
Proteasome inhibitor + Immunomodulator
Sensitive: C3 – Early Trials
Chr t(4;14)
Multiple Myeloma
bortezomib
Resistant: C3 – Early Trials
Chr t(4;14)
Multiple Myeloma
midostaurin
Sensitive: D – Preclinical
Chr t(4;14)
Multiple Myeloma
PFI-3
Sensitive: D – Preclinical